Vascepa is a prescription medication that contains the active ingredient eicosapentaenoic acid (EPA), which is an omega-3 fatty acid found in fish oil. It is used to lower triglyceride levels in adults with severe hypertriglyceridemia. While there is no evidence to suggest that Vascepa can enhance the effects of supplements, it is important to note that it may interact with certain supplements or other medications.
According to the Drug Patent Watch [1], Vascepa is a prescription medication that is used to lower triglyceride levels in adults with severe hypertriglyceridemia. It contains EPA, which is an omega-3 fatty acid found in fish oil. Vascepa works by reducing the production of triglycerides in the liver, which can help to lower the risk of heart disease.
A study published in the Journal of Clinical Lipidology [2] found that Vascepa was effective in reducing triglyceride levels in patients with severe hypertriglyceridemia. The study also found that Vascepa was well-tolerated and did not have any significant side effects.
While there is no evidence to suggest that Vascepa can enhance the effects of supplements, it is important to note that it may interact with certain supplements or other medications. For example, Vascepa may increase the risk of bleeding when taken with blood-thinning medications such as warfarin [3]. It is important to talk to a healthcare provider before taking any supplements or medications with Vascepa to avoid potential interactions.
In conclusion, Vascepa is a prescription medication that contains EPA and is used to lower triglyceride levels in adults with severe hypertriglyceridemia. While there is no evidence to suggest that Vascepa can enhance the effects of supplements, it is important to talk to a healthcare provider before taking any supplements or medications with Vascepa to avoid potential interactions.
Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671468/
[3] https://www.medicalnewstoday.com/articles/drugs-vascepa